Faraz Nasim Kazmi, MBBS

Faraz Nasim Kazmi practices at Mercyhealth Physicians - HOPD in Rockford, Illinois.

Faraz Nasim Kazmi's NPI, 1306286463, was assigned on July 2, 2013. Faraz Nasim Kazmi holds Minnesota license 66649.

Faraz Nasim Kazmi's primary practice is Mercyhealth Physicians - HOPD, at 2300 N Rockton Ave, Rockford, IL 61103.

Faraz Nasim Kazmi's primary practice is Mercyhealth Physicians - HOPD in Rockford, Illinois. Faraz Nasim Kazmi is also affiliated with Javon Bea Hospital-Riverside. The medical group on file is Mercyhealth Physicians. Dmand AI also links Faraz Nasim Kazmi to 2 more hospitals, 3 medical groups and 2 group practices and clinics, each named with a free account. Faraz Nasim Kazmi's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Faraz Nasim Kazmi practices, 6 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Faraz Nasim Kazmi's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dmand AI has Faraz Nasim Kazmi's licenses on file in 4 states: Minnesota, Connecticut, Illinois and Wisconsin.

CMS data shows 643 Medicare services from Faraz Nasim Kazmi across 15 procedure codes in 2024, for 440 Medicare patients. Medicare paid $39,144 for them.

CMS counts 440 Medicare patients who saw Faraz Nasim Kazmi in 2024. The largest group is 65 to 74, with 177 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 1.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Faraz Nasim Kazmi's median patient age at 73, with 49% women.

In 2024, Faraz Nasim Kazmi wrote 3,080 Medicare Part D claims for 513 patients. 79% of them were for generic drugs. CMS names the drug for 2,952 of them, across 33 drugs with 11 or more claims each, at $630,115 in total drug cost. In 2023, CMS named 2,264 claims across 32 drugs.

Faraz Nasim Kazmi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 29 procedures of coronary angioplasty and stenting by Faraz Nasim Kazmi, more than 64% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 68 general payments to Faraz Nasim Kazmi from 19 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 61% of the total. Boston Scientific Corporation paid the most, $1,629.